Search Results - "de Backer, Tine"

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study by Grymonprez, Maxim, De Backer, Tine L, Bertels, Xander, Steurbaut, Stephane, Lahousse, Lies

“…Although non-vitamin K antagonist oral anticoagulants (NOACs) are recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management, direct…”
Get full text

Carotid to femoral pulse wave velocity: a comparison of real travelled aortic path lengths determined by MRI and superficial measurements by Huybrechts, Sofie A.M, Devos, Daniel G, Vermeersch, Sebastian J, Mahieu, Dries, Achten, Eric, de Backer, Tine L.M, Segers, Patrick, van Bortel, Luc M

“…OBJECTIVESCarotid–femoral pulse wave velocity (PWV) is the gold standard method for determination of arterial stiffness. PWV is assessed by dividing travelled…”
Get full text

Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis by Grymonprez, Maxim, Steurbaut, Stephane, De Backer, Tine L, Petrovic, Mirko, Lahousse, Lies

“…Atrial fibrillation (AF), the most common cardiac arrhythmia, typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to…”
Get full text

Propionyl-L-carnitine for intermittent claudication by Kamoen, Victor, Vander Stichele, Robert, Campens, Laurence, De Bacquer, Dirk, Van Bortel, Luc, de Backer, Tine Lm

“…Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis. Intermittent claudication is a symptomatic form of PAD that is characterized…”
Get more information

The sEROtonergic pathway: a hERO for the brain, a zERO for the valves? by De Backer, Tine L M, Timmermans, Frank

Get more information

Naftidrofuryl for intermittent claudication by de Backer, Tine L M, Vander Stichele, Robert, Lehert, Philippe, Van Bortel, Luc

“…Lifestyle changes and cardiovascular prevention measures are a primary treatment for intermittent claudication (IC). Symptomatic treatment with vasoactive…”
Get more information

Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers–Danlos syndrome by De Wandele, Inge, MSc, PT, Rombaut, Lies, PhD, PT, Leybaert, Luc, PhD, MD, Van de Borne, Philippe, PhD, MD, De Backer, Tine, PhD, MD, Malfait, Fransiska, PhD, MD, De Paepe, Anne, PhD, MD, Calders, Patrick, PhD

“…Abstract Objectives Many non-musculoskeletal complaints in EDS-HT may be related to dysautonomia. This study therefore aims to investigate whether dysautonomia…”
Get full text

A Long and Winding Road from Tortuous Arteries to a Straightforward Diagnosis of FMD by De Backer, Tine L. M., De Buyzere, Marc L. D.

Get full text

Noninvasive assessment of carotid-femoral pulse wave velocity: the influence of body side and body contours by Bossuyt, Jelle, Van De Velde, Sandrien, Azermai, Majda, Vermeersch, Sebastian J, De Backer, Tine L.M, Devos, Daniel G, Heyse, Catherine, Filipovsky, Jan, Segers, Patrick, Van Bortel, Luc M

“…BACKGROUND:Recently, an expert group advised to measure carotid-femoral (cf) pulse wave velocity (PWV) on the right side of the body, and to use a sliding…”
Get full text

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study by Grymonprez, Maxim, Capiau, Andreas, Steurbaut, Stephane, Mehuys, Els, Boussery, Koen, De Backer, Tine L., Lahousse, Lies

“…Background Since non-vitamin K antagonist oral anticoagulants (NOACs) do not require coagulation monitoring, concerns of lower adherence and persistence to…”
Get full text

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study by Grymonprez, Maxim, Petrovic, Mirko, De Backer, Tine L., Steurbaut, Stephane, Lahousse, Lies

“…Data on non-vitamin K antagonist oral anticoagulant (NOAC) use in patients with atrial fibrillation (AF) and a history of falls are limited. Therefore, we…”
Get full text

Vascular Dysregulation in Normal-Tension Glaucoma Is Not Affected by Structure and Function of the Microcirculation or Macrocirculation at Rest: A Case–Control Study by Bossuyt, Jelle, Vandekerckhove, Gwendolijn, De Backer, Tine L.M., Van de Velde, Sandrien, Azermai, Majda, Stevens, Anna-Maria, Kestelyn, Philippe, Raemdonck, Tia, Segers, Patrick, Vanmolkot, Floris, Van Bortel, Luc M.

“…In normal-tension glaucoma (NTG), optic nerve damage occurs despite a normal intraocular pressure. Studies implicating systemic blood pressure or, more…”
Get full text

Asymmetry in prevalence of femoral but not carotid atherosclerosis by Bossuyt, Jelle, Van Bortel, Luc M, De Backer, Tine L M, Van De Velde, Sandrien, Azermai, Majda, Segers, Patrick, De Buyzere, Marc, Van Daele, Caroline, Rietzschel, Ernst

“…Atherosclerotic disease is caused by a combination of systemic and local factors (e.g. geometry) affecting local flow conditions. In contrast to the carotid…”
Get full text

Buflomedil for intermittent claudication by de Backer, Tine L M, Vander Stichele, Robert

“…Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest…”
Get more information

Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis by Grymonprez, Maxim, Simoens, Cynthia, Steurbaut, Stephane, De Backer, Tine L, Lahousse, Lies

“…Non-vitamin K antagonist oral anticoagulants (NOACs) are effective and safe alternatives compared with vitamin K antagonists (VKAs) for thromboembolic…”
Get full text

Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis by Grymonprez, Maxim, De Backer, Tine L., Steurbaut, Stephane, Boussery, Koen, Lahousse, Lies

“…Purpose Oral anticoagulants are crucial for preventing systemic thromboembolism in atrial fibrillation (AF), with guidelines preferring non-vitamin K…”
Get full text

Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis by Grymonprez, Maxim, Vanspranghe, Kevin, Steurbaut, Stephane, De Backer, Tine L., Lahousse, Lies

“…Purpose Non-vitamin K antagonist oral anticoagulants (NOACs) are excreted by P-glycoprotein (P-gp) and some are metabolized by CYP450 enzymes such as CYP3A4…”
Get full text

Antihypertensive treatment in a general uncontrolled hypertensive population in Belgium and Luxembourg in primary care: Therapeutic inertia and treatment simplification. The SIMPLIFY study by De Backer, Tine, Van Nieuwenhuyse, Bregt, De Bacquer, Dirk

“…Despite effective treatments, blood pressure (BP) control remains suboptimal. The SIMPLIFY study aimed at identifying key factors related to therapeutic…”
Get full text

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study by Grymonprez, Maxim, Petrovic, Mirko, De Backer, Tine L, Ikram, M Arfan, Steurbaut, Stephane, Lahousse, Lies

“…Abstract Background Atrial fibrillation (AF) is associated with cognitive decline, with anticoagulated subjects potentially having a reduced risk compared with…”
Get full text

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study by Grymonprez, Maxim, De Backer, Tine L., Capiau, Andreas, Vauterin, Delphine, Mehuys, Els, Boussery, Koen, Steurbaut, Stephane, Lahousse, Lies

“…Aim Non‐vitamin K antagonist oral anticoagulants (NOACs) are increasingly preferred over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management…”
Get full text